Side Effects of topotecan injection: A Synthesis of Findings from 6 Studies
- Home
- Side Effects of topotecan injection
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of topotecan injection: A Synthesis of Findings from 6 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Topotecan is a chemotherapy drug used to treat various cancers such as refractory leptomeningeal leukemia in children, retinoblastoma, and neoplastic meningitis in adults. Topotecan works by inhibiting cell DNA replication, thus suppressing the growth of cancer cells. 4 , 1 , 3
Reasons for Side Effects
The side effects of topotecan occur because it affects normal cells as well as cancer cells. Topotecan inhibits DNA replication and thus affects cell growth and division, leading to side effects. 2
Common Side Effects
Chemical Meningitis
Topotecan can cause chemical meningitis when administered intrathecally. Chemical meningitis is caused by inflammation of the cerebrospinal fluid and can cause symptoms such as headache, fever, vomiting, and stiff neck. 3
Effects on Retinal Vessels
Topotecan can affect retinal vessels. Topotecan inhibits the formation of retinal vessels and can cause abnormal vascularization and occlusion. 2
Other Side Effects
Other side effects of topotecan include nausea, vomiting, loss of appetite, hair loss, myelosuppression, and infections. , 3
Side Effects Management
Managing Chemical Meningitis
Managing chemical meningitis involves administering steroid medications. 3
Managing Effects on Retinal Vessels
Managing effects on retinal vessels involves adjusting the dose of topotecan or changing the method of administration. 2
Managing Other Side Effects
Managing other side effects involves using anti-emetics for nausea and vomiting, and hematopoietic factors for myelosuppression. 3
Comparison Between Studies
Commonalities Across Studies
Multiple studies have shown that topotecan is effective in inhibiting the growth of cancer cells. 4 , 1 , 3 , 6 , 5 All studies have indicated that topotecan can cause side effects. , 2 , 3
Differences Across Studies
The frequency and severity of side effects following topotecan administration vary between studies. This could be due to differences in the patient populations, methods of administration, and dosages of topotecan used in the studies. , 2 , 3
Considerations for Real-World Application
Topotecan is an effective drug for treating cancer, but it is important to remember that there are risks associated with side effects. When administering topotecan, it is crucial to follow the doctor's instructions and ensure a full understanding of the potential side effects for safe use. 4 , 1 , 3
Limitations of Current Research
Research on the side effects of topotecan is still insufficient. Future research is needed to investigate the frequency and severity of side effects in more detail and develop methods to mitigate them. 4 , 1 , 3
Future Research Directions
Future research needs to focus on developing new treatments and medications to reduce the side effects of topotecan, as well as researching combination therapies with other drugs. 4 , 1 , 3
Conclusion
Topotecan is an effective drug for treating cancer, but it carries the risk of side effects. When administering topotecan, it is essential to follow the doctor's instructions and have a thorough understanding of the potential side effects for safe use. Future research is expected to lead to a deeper understanding of the side effects of topotecan, making it safer and more effective for use. 4 , 1 , 3
Benefit Keywords
Risk Keywords
Article Type
Author: DelrishElham, JabbarvandMahmoud, GhassemiFariba, AmoliFahimeh Asadi, AtyabiFatemeh, LashayAlireza, SoleimaniMasoud, AghajanpourLeila, DinarvandRassoul
Language : English
Author: PescosolidoN, PascarellaA, ScarsellaG, TafaniM, StefaniniS, NebbiosoM
Language : English
Author: GrovesMorris D, GlantzMichael J, ChamberlainMarc C, BaumgartnerKaren E, ConradCharles A, HsuSigmund, WefelJeffrey S, GilbertMark R, IctechSandra, HunterKathy U, FormanArthur D, PuduvalliVinay K, ColmanHoward, HessKenneth R, YungW K Alfred
Language : English
Author: PotterSamara L Poplack, BergStacey, IngleAshish Mark, KrailoMark, AdamsonPeter C, BlaneySusan M
Language : English
Author: GammonDavid C, BhattMansi S, TranLan, Van HornAlexis, BenvenutiMatthew, GlantzMichael J
Language : English
Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer.
Author: HasenburgA, TongX W, Rojas-MartinezA, Nyberg-HoffmanC, KiebackC C, KaplanA, KaufmanR H, RamzyI, Aguilar-CordovaE, KiebackD G
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.